Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin)

Peer Review reports

Original Submission
18 Apr 2013	Submitted	Original manuscript
7 May 2013	Author responded	Author comments - Deanna Kelly
Resubmission - Version 2
7 May 2013	Submitted	Manuscript version 2
Publishing
7 Aug 2013	Editorially accepted
22 Aug 2013	Article published	10.1186/1471-244X-13-214

Back to article page